VANDA PHARMACEUTICALS INC. (VNDA)
Vanda Pharmaceuticals Announces Initiation of The Thetis Study, a Clinical Trial of NEREUS™ for the Prevention of Vomiting Induced by GLP-1 Receptor Agonists
Vanda Pharmaceuticals Announces Initiation of The Thetis Study, a Clinical Trial of NEREUS™ for the Prevention of Vomiting Induced by GLP-1 Receptor Agonists
JCDecaux remporte l’appel d’offres pour la concession publicitaire de Western Sydney International, le nouvel aéroport ouvert 24h/24
JCDecaux wins advertising tender for Western Sydney International Airport, Sydney’s new 24-hour airport
Western Alliance Bancorporation Announces First Quarter 2026 Earnings Release Date, Conference Call and Webcast
Vornado Releases 2025 Sustainability Report
UTHR: Notification
UPST Investors Have Opportunity to Lead Upstart Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm
Pioneer Power Announces Financial Results for Fourth Quarter and Full Year 2025
Fortis Inc. to Hold Teleconference and Webcast on May 6 to Discuss First Quarter 2026 Results and Hold Annual Meeting on May 7
Norwood Financial Corp Announces Timing of First Quarter 2026 Earnings Release and Conference Call